The last major study of the prevalence of schizophrenia in the US was carried out in the early 1980s. The results from that study have been used for 3 decades.
E. Fuller Torrey, MD
How to decrease recidivism for individuals with serious mental illnesses who are released from jails or prisons or discharged from hospitals? Here are several effective mechanisms.
After lounging on the doorstep of respectability for the past decade, assisted outpatient treatment is here to stay. But some still balk at the notion.
Here: common misconceptions about assisted outpatient treatment--and how this tool can help selected mentally ill patients who are most difficult to treat.
Individuals with serious mental illness are responsible for more than 7% of the nation’s homicides. What can be done to reduce this deadly phenomenon?
Reasons for the overall low rate of clozapine use brings to light questionable decisions on the part of policymakers
The current shortage of psychiatric beds in the US is a major problem. Patients are discharged prematurely and often have to be readmitted or end up homeless or incarcerated.
A report on Medicaid and Medicare fraud, excessive waste, and frivolous expenditures—all at the expense of those who suffer from psychiatric illness.
The funding of mental illness services in the US is more thought-disordered than any of the thought-disordered patients it is meant to serve.
Clearly, some with schizophrenia fare better without antipsychotic drugs. But not all. Many individuals with schizophrenia are better off taking antipsychotic drugs for long-term.